用户名: 密码: 验证码:
Combination of UHPLC/Q-TOF-MS, NMR spectroscopy, and ECD calculation for screening and identification of reactive metabolites of gentiopicroside in humans
详细信息    查看全文
  • 作者:Han Han (1) (2)
    Ai-Zhen Xiong (1) (2)
    Chun-Yong He (1) (2)
    Qing Liu (1) (2)
    Li Yang (1) (2)
    Zheng-Tao Wang (1) (2)
  • 关键词:UHPLC/Q ; TOF ; MS ; ECD calculation ; Identification ; Gentiopicroside ; Metabolic reaction
  • 刊名:Analytical and Bioanalytical Chemistry
  • 出版年:2014
  • 出版时间:February 2014
  • 年:2014
  • 卷:406
  • 期:6
  • 页码:1781-1793
  • 全文大小:623 KB
  • 参考文献:1. White NJ (2008) Science 320:330-34 CrossRef
    2. Newman DJ, Cragg GM (2012) J Nat Prod 75:311-35 CrossRef
    3. Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ (2010) N Engl J Med 362:1663-674 CrossRef
    4. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB (2006) Diabetes 55:2256-264 CrossRef
    5. Gao CY, Chen XY, Zhong DF (2011) Drug Metab Dispos 39:2034-044 CrossRef
    6. Zhou SF, Xue CC, Yu XQ, Wang G (2007) Curr Drug Metab 8:526-53 CrossRef
    7. Shoda J, Miura T, Utsunomiya H, Oda K, Yamamoto M, Kano M, Ikegami T, Tanaka N, Akita H, Ito K, Suzuki H, Sugiyama Y (2004) Hepatology 39:167-78 CrossRef
    8. Tony P, Martin B (2002) Drug Discov Today 7:554 CrossRef
    9. Tang W, Lu AY (2009) Curr Pharm Des 15:2170-183 CrossRef
    10. Zhang D, Zhu M, Humphreys WG (2008) Drug Metabolism in Drug Design and Development. John Wiley & Sons, Hoboken
    11. Anders MW (1971) Annu Rev Pharmacol 11:37-6 CrossRef
    12. Meermann B, Hulstaert A, Laenen A, Van Looveren C, Vliegen M, Cuyckens F, Vanhaecke F (2012) Anal Chem 84:2395-401 CrossRef
    13. Horstk?tter C, Schepmann D, Blaschke G (2003) J Chromatogr A 1014:71 CrossRef
    14. Zhou Y, Xu G, Choi FF, Ding LS, Han QB, Song JZ, Qiao CF, Zhao QS, Xu HX (2009) J Chromatogr A 1216:4847-858 CrossRef
    15. Cargile BJ, Bundy JL, Stephenson JL Jr (2004) J Proteome Res 3:1082-085 CrossRef
    16. Abdenur JE, Chamoles NA, Guinle AE, Schenone AB, Fuertes AN (1998) J Inherited Metab Dis 21:624-30 CrossRef
    17. Walker GS, O’Connell TN (2008) Expert Opin Drug Metab Toxicol 4:1295-305 CrossRef
    18. Geier FM, Want EJ, Leroi AM, Bundy JG (2011) Anal Chem 83:3730-736 CrossRef
    19. Jia CQ, Shi HM, Jin W, Zhang K, Jiang Y, Zhao MB, Tu PF (2009) Drug Metab Dispos 37:431-38 CrossRef
    20. Gillotin F, Chiap P, Frédérich M, Van Heugen JC, Francotte P, Lebrun P, Pirotte B, de Tullio P (2010) Drug Metab Dispos 38:232-40 CrossRef
    21. Fredenhagen A, Kittelmann M, Oberer L, Kuhn A, Kühn?l J, Délémonté T, Aichholz R, Wang P, Atadja P, Shultz MD (2012) Drug Metab Dispos 40:1041-050 CrossRef
    22. Fabro S, Smith RL, Williams RT (1967) Nature 215:296 CrossRef
    23. Totta P, Acconcia F, Virgili F, Cassidy A, Weinberg PD, Rimbach G, Marino M (2005) J Nutr 135:2687-693
    24. van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agrò A, Vliegenthart JF, Maccarrone MJ (2002) J Med Chem 45:3709-720 CrossRef
    25. Matsukawa K, Ogata M, Hikage T, Minami H, Shimotai Y, Saitoh Y, Yamashita T, Ouchi A, Tsutsumi R, Fujioka T, Tsutsumi K (2006) Biosci Biotechnol Biochem 70:1046-048 CrossRef
    26. Chen L, Liu JC, Zhang XN, Guo YY, Xu ZH, Cao W, Sun XL, Sun WJ, Zhao MG (2008) Neuropharmacology 54:1175-181 CrossRef
    27. Oztürk N, Korkmaz S, Oztürk Y, Ba?er KH (2006) Planta Med 72:289-94 CrossRef
    28. Lian LH, Wu YL, Wan Y, Li X, Xie WX, Nan JX (2010) J Chem Biol Interact 188:127-33 CrossRef
    29. Wang AY, Lian LH, Jiang YZ, Wu YL, Nan JX (2010) World J Gastroenterol 16:384-91 CrossRef
    30. Lian LH, Wu YL, Song SZ, Wan Y, Xie WX, Li X, Bai T, Ouyang BQ, Nan JX (2010) J Agric Food Chem 58:13013-3019 CrossRef
    31. Chineses Pharmacopoeia Commission. (2010) Pharmacopoeia of the People’s Republic of China. Beijing
    32. Wang D, Xu M, Zhu HT, Chen KK, Zhang YJ, Yang CR (2007) Bioorg Med Chem Lett 17:3195-197 CrossRef
    33. Popov SS, Marekov NL, Do TN (1988) J Nat Prod 51:765-68 CrossRef
    34. el-Sedawy AI, Hattori M, Kobashi K, Namba T (1989) Chem Pharm Bull 37:2435-437 CrossRef
    35. Zeng WL, Han H, Tao YY, Yang L, Wang ZT, Chen KX (2013) Biomed Chromatogr 27:1129-136 CrossRef
    36. Wang CH, Cheng XM, Bligh SW, White KN, Branford-White CJ, Wang ZT (2007) J Pharm Biomed Anal 44:1113-117 CrossRef
    37. Cogne AL, Queiroz EF, Marston A, Wolfender JL, Mavi S, Hostettmann K (2005) Phytochem Anal 16:429-39 CrossRef
    38. Zhang L, Yu Q, He J, Zha X (2004) Mol Cell Biochem 262:25-3 CrossRef
    39. McLafferty FW (1959) Anal Chem 31:82-7 CrossRef
    40. Baghdikian B, Guiraud-Dauriac H, Ollivier E, N’Guyen A, Dumenil G, Balansard G (1999) Planta Med 65:164-66 CrossRef
    41. El-Sedawy AI, Shu YZ, Hattori M, Kobashi K, Namba T (1989) Planta Med 55:147-50 CrossRef
    42. Han H, Yang L, Xu Y, Ding Y, Bligh SW, Zhang T, Wang ZT (2011) Rapid Commun Mass Spectrom 25:3339-350 CrossRef
    43. Inouye H, Ueda S, Takeda Y (1968) Tetrahedron Lett 30:3453-458 CrossRef
    44. Dr?ge W (2002) Physiol Rev 82:47-5
    45. Wang T, Weinman SA (2006) J Gastroenterol Hepatol 21:S34–S37 CrossRef
    46. Chou CC, Pan SL, Teng CM, Guh JH (2003) Eur J Pharm Sci 19:403-12 CrossRef
    47. Stephens PJ, Devlin FJ, Gasparrini F, Ciogli A, Spinelli D, Cosimelli B (2007) J Org Chem 72:4707-715 CrossRef
    48. Berova N, Di Bari L, Pescitelli G (2007) Chem Soc Rev 36:914-31 CrossRef
    49. Yang XW, Ding Y, Li XC, Ferreira D, Shen YH, Li SM, Wang N, Zhang WD (2009) Chem Commun 7:3771-773 CrossRef
    50. Jenner P, Testa B (1973) Drug Metab Rev 2:117-84 CrossRef
    51. Long JP, Luduena FP, Tullar BF, Lands AM (1956) J Pharmacol Exp Ther 117:29-7
    52. Hutt AJ (2007) Drug Metab Drug Interact 22:79-12
    53. Pereillo JM, Maftouh M, Andrieu A, Uzabiaga MF, Fedeli O, Savi P, Pascal M, Herbert JM, Maffrand JP, Picard C (2002) Drug Metab Dispos 30:1288-295 CrossRef
  • 作者单位:Han Han (1) (2)
    Ai-Zhen Xiong (1) (2)
    Chun-Yong He (1) (2)
    Qing Liu (1) (2)
    Li Yang (1) (2)
    Zheng-Tao Wang (1) (2)

    1. The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Traditional Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, 201210, China
    2. The State Administration of TCM (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Traditional Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, 201210, China
  • ISSN:1618-2650
文摘
The metabolic investigation of natural products is a great challenge because of unpredictable metabolic pathways, little knowledge on metabolic effects, and lack of recommended analytical methodology. Herein, a combined strategy based on ultrahigh-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry (UHPLC/Q-TOF-MS), nuclear magnetic resonance (NMR) spectroscopy, and electronic circular dichroism (ECD) calculation was developed and employed for the human metabolism study of gentiopicroside (GPS), a naturally hepato-protective iridoid glycoside. The whole metabolic study consisted of three major procedures. First, an improved UHPLC/Q-TOF-MS method was used to separate and detect a total of 15 GPS metabolites that were obtained from urine samples (0 to 72?h) of 12 healthy male participants after a single 50-mg oral dose of GPS. Second, a developed “MS-NMR-MS-method was applied to accurately identify molecular structures of the observed metabolites. Finally, given that the associated stereochemistry may be a crucial factor of the metabolic activation, the absolute configuration of the reactive metabolites was revealed through chemical calculations. Based on the combined use, a pair of diastereoisomers (G05 and G06) were experimentally addressed as the bioreactive metabolites of GPS, and the stereochemical determination was completed. Whereas several novel metabolic transformations, occurring via oxidation, N-heterocyclization and glucuronidation after deglycosylation, were also observed. The results indicated that GPS has to undergo in vivo metabolism-based activation to generate reactive molecules capable of processing its hepato-protective activity. Figure Identification of metabolites of gentiopicroside using a combined strategy

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700